Your session is about to expire
What is Cladribine
Approved as Treatment by the FDA
Cladribine, also called Leustatin, is approved by the FDA for 2 uses which include Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia .Effectiveness
When to interrupt dosage
The endorsed measure of Cladribine is subject to the diagnosed condition, for example Non-Hodgkin's Lymphoma, Hairy Cell Leukemia and Chronic Lymphocytic Leukemia. The quantity of dosage can be found in the table below, contingent upon the technique of delivery (e.g. Solution - Intravenous or Injection).Warnings
There are 20 known major drug interactions with Cladribine.Cladribine Novel Uses: Which Conditions Have a Clinical Trial Featuring Cladribine?
At present, there are 380 ongoing trials investigating the potential of Cladribine to target CTAGE1 protein, human, Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma.Cladribine Reviews: What are patients saying about Cladribine?
Patient Q&A Section about cladribine
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.What is cladribine used for?
"This medication is used to treat hairy cell leukemia (a cancer of a certain type of white blood cell). It works by slowing or stopping the growth of cancer cells."
What type of chemo is cladribine?
"How this drug works: Cladribine works by killing cancer cells or by stopping their growth.
Cladribine is an anti-cancer drug that kills cancer cells or prevents their growth."
How does cladribine work in MS?
"This medication is used to treat relapsing forms of multiple sclerosis. It is not a cure, but it is thought to work by preventing immune system cells from attacking the nerves in the brain and spinal cord. This may help to slow disease progression and reduce the severity of flare-ups."
Is cladribine a chemotherapy?
"Cladribine is a chemotherapy drug that is mainly used to treat hairy cell leukemia, but it can also be used to treat other types of leukemia."